IL17A and sarcoma: Meanwhile, an application of anti-IL-17 (i.t., 2 μg) on day 14 following sarcoma cell implantation ameliorated the existing mechanical allodynia (F (1, 50) = 20.96, p < 0.0001, n = 6, two-way ANOVA; Figure 5D) and thermal hyperalgesia (F (1, 50) = 4.404, p = 0.0409, n = 6, two-way ANOVA; Figure 5E).